Palatin Technologies
PTN
#9856
Rank
NZ$75.67 M
Marketcap
NZ$44.44
Share price
-8.18%
Change (1 day)
3,001.32%
Change (1 year)

Palatin Technologies (PTN) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$14.89 Million

According to Palatin Technologies's latest financial reports the company's total assets are NZ$14.89 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Palatin Technologies - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-06-30NZ$17.61 M-39.78%
2023-06-30NZ$29.24 M-49.4%
2022-06-30NZ$57.8 M-39.9%
2021-06-30NZ$96.18 M-27.05%
2020-06-30NZ$0.13 B-15.37%
2019-06-30NZ$0.15 B170.39%
2018-06-30NZ$57.61 M-25.78%
2017-06-30NZ$77.62 M410.2%
2016-06-30NZ$15.21 M-64.96%
2015-06-30NZ$43.42 M203%
2014-06-30NZ$14.33 M-55.77%
2013-06-30NZ$32.4 M383.33%
2012-06-30NZ$6.7 M-73.77%
2011-06-30NZ$25.55 M42.71%
2010-06-30NZ$17.91 M-13.01%
2009-06-30NZ$20.58 M-18.1%
2008-06-30NZ$25.13 M-54.83%
2007-06-30NZ$55.65 M-15.84%
2006-06-30NZ$66.12 M28.61%
2005-06-30NZ$51.41 M18.28%
2004-06-30NZ$43.46 M11.38%
2003-06-30NZ$39.02 M53.48%
2002-06-30NZ$25.42 M-27.42%
2001-06-30NZ$35.03 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
MediciNova
MNOV
NZ$82.24 M 452.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
NZ$10.35 M-30.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$7.37 B 49,416.75%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$2.43 B 16,245.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$2.55 B 17,042.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$333.30 B 2,238,131.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
NZ$0.84 B 5,543.52%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$197.84 B 1,328,518.89%๐Ÿ‡ฌ๐Ÿ‡ง UK